Edmonton, Canada

Yi-Chan James Lin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yi-Chan James Lin: Innovator in Phytoestrogen Research

Introduction

Yi-Chan James Lin is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of phytoestrogen products derived from red clover. With a total of 3 patents to his name, Lin's work focuses on addressing postmenopausal symptoms through innovative compositions.

Latest Patents

One of Lin's latest patents is titled "Phytoestrogen product of red clover and pharmaceutical uses thereof." This invention provides compositions that comprise optimized ratios of red clover phytoestrogens, determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are designed to modulate, prevent, or treat postmenopausal or climacteric symptoms, including bone loss, bone remodeling, hot flushes, and vaginal atrophy. Additionally, the patent outlines methods for utilizing these compositions to effectively manage these symptoms.

Career Highlights

Throughout his career, Yi-Chan James Lin has worked with various companies, including Sinoveda Canada Inc. and Main Harbour Biotech International Limited. His experience in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Lin has collaborated with notable individuals in his field, including Yun Kau Tam and Brian Duff Sloley. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yi-Chan James Lin is a distinguished inventor whose work in phytoestrogen research has the potential to significantly impact the treatment of postmenopausal symptoms. His innovative approaches and collaborations highlight his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…